Neuroendocrine Tumors market, By Type (Gastrointestinal NETs, Pancreatic NETs and Lung NETs), By Treatment, By Diagnosis, By End-User, By Country, and By Region - Industry Analysis, market Size, market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Neuroendocrine Tumors Market size was valued at USD 3,490.23 Million in 2023, expanding at a CAGR of 10.44% from 2024 to 2032.
The Neuroendocrine Tumors (NETs) market pertains to the healthcare industry focused on the diagnosis, treatment, and management of neuroendocrine tumors. These tumors arise from neuroendocrine cells, which have characteristics of both nerve cells and hormone-producing endocrine cells. NETs are most commonly found in the lungs, pancreas, and gastrointestinal tract. The market includes diagnostic techniques such as imaging and biopsy, as well as therapies like surgery, chemotherapy, radiation therapy, and targeted drug treatments. The growing prevalence of NETs, advancements in treatment options, and an increasing awareness of the disease contribute to market growth. The development of novel therapies, including somatostatin analogs and targeted therapies, has also been a key driver. Additionally, the rising demand for personalized medicine and more effective treatment options supports market expansion. The global market is impacted by regulatory approvals, technological advancements, and the availability of specialized healthcare services.
Neuroendocrine Tumors Market- Market Dynamics
Rising awareness and early detection of neuroendocrine tumors drive market growth.
Rising awareness and early detection of neuroendocrine tumors (NETs) are key drivers for the market. As more people become informed about the symptoms and risks associated with NETs, early diagnosis becomes possible, leading to improved patient outcomes. This growing awareness is supported by health organizations, which emphasize the importance of early detection in the treatment of NETs. Early-stage detection often allows for more effective interventions, such as surgery or targeted therapies, which can significantly improve survival rates. For instance, the National Cancer Institute reports that the 5-year relative survival rate for localized pancreatic neuroendocrine tumors is approximately 97% when detected early. Increased public awareness campaigns, coupled with advancements in diagnostic technology, are also helping to identify these tumors at earlier stages, further contributing to market growth. This heightened awareness fosters demand for diagnostic tools, therapies, and support services, creating a robust market environment.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NEUROENDOCRINE TUMORS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Novartis
Ipsen
Pfizer
Sanofi
Bristol-Myers Squibb
AbbVie
Hikma Pharmaceuticals
Astellas Pharma
Medtronic
F. Hoffmann-La Roche
Eli Lilly and Company
Bayer
Lantheus Medical Imaging
Merck & Co.
GLOBAL NEUROENDOCRINE TUMORS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
Gastrointestinal NETs
Pancreatic NETs
Lung NETs
Others
GLOBAL NEUROENDOCRINE TUMORS MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032
Chemotherapy
Somatostatin Analogs
Targeted Therapy
Peptide Receptor Radionuclide Therapy (PRRT)
Surgery
Immunotherapy
GLOBAL NEUROENDOCRINE TUMORS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032
Imaging
Biopsy
Blood Tests
GLOBAL NEUROENDOCRINE TUMORS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
Hospitals
Cancer Centers
Diagnostic Laboratories
Ambulatory Surgical Centers
GLOBAL NEUROENDOCRINE TUMORS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Neuroendocrine Tumors Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Neuroendocrine Tumors Market Snippet by Type
2.1.2. Neuroendocrine Tumors Market Snippet by Treatment
2.1.3. Neuroendocrine Tumors Market Snippet by Diagnosis
2.1.4. Neuroendocrine Tumors Market Snippet by End-User
2.1.5. Neuroendocrine Tumors Market Snippet by Country
2.1.6. Neuroendocrine Tumors Market Snippet by Region
2.2. Competitive Insights
3. Neuroendocrine Tumors Key Market Trends
3.1. Neuroendocrine Tumors Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Neuroendocrine Tumors Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Neuroendocrine Tumors Market Opportunities
3.4. Neuroendocrine Tumors Market Future Trends
4. Neuroendocrine Tumors Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Neuroendocrine Tumors Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Neuroendocrine Tumors Market Landscape
6.1. Neuroendocrine Tumors Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Neuroendocrine Tumors Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
7.1.2. Gastrointestinal NETs
7.1.3. Pancreatic NETs
7.1.4. Lung NETs
7.1.5. Others
8. Neuroendocrine Tumors Market – By Treatment
8.1. Overview
8.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
8.1.2. Chemotherapy
8.1.3. Somatostatin Analogs
8.1.4. Targeted Therapy
8.1.5. Peptide Receptor Radionuclide Therapy (PRRT)
8.1.6. Surgery
8.1.7. Immunotherapy
9. Neuroendocrine Tumors Market – By Diagnosis
9.1. Overview
9.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
9.1.2. Imaging
9.1.3. Biopsy
9.1.4. Blood Tests
10. Neuroendocrine Tumors Market – By End-User
10.1. Overview
10.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
10.1.2. Hospitals
10.1.3. Cancer Centers
10.1.4. Diagnostic Laboratories
10.1.5. Ambulatory Surgical Centers
11. Neuroendocrine Tumors Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Neuroendocrine Tumors Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.2.8. The U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Neuroendocrine Tumors Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Neuroendocrine Tumors Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Neuroendocrine Tumors Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Neuroendocrine Tumors Key Manufacturers in the Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Neuroendocrine Tumors Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Novartis
12.2.2. Ipsen
12.2.3. Pfizer
12.2.4. Sanofi
12.2.5. Bristol-Myers Squibb
12.2.6. AbbVie
12.2.7. Hikma Pharmaceuticals
12.2.8. Astellas Pharma
12.2.9. Medtronic
12.2.10. F. Hoffmann-La Roche
12.2.11. Eli Lilly and Company
12.2.12. Bayer
12.2.13. Lantheus Medical Imaging
12.2.14. Merck & Co.
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
